SCHEMBL5652791

SCHEMBL5652791

CCNC(=O)N1[CH]CCCC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.35
EPHX1 P07099 1/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 2/20 0.33
BCHE P06276 1/20 0.33
TP53 P04637 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
MEN1 O00255 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
BRD4 O60885 1/20 0.31
ALDH1A1 P00352 3/20 0.31
KDM4E B2RXH2 2/20 0.31
POLB P06746 2/20 0.30
MAPK1 P28482 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2644912 0.75 L3MBTL1 (0.38) KMT2AHTTSMN1; SMN2MAPTL3MBTL1
SCHEMBL2646658 0.73 L3MBTL1 (0.46) KMT2ASMN1; SMN2MAPTTP53NPC1
SCHEMBL2840680 0.72
SCHEMBL360407 0.72 TSHR (0.39) KMT2AHTTSMN1; SMN2GAAMAPT
SCHEMBL7837036 0.72 L3MBTL1 (0.53) KMT2ASMN1; SMN2MAPTTP53L3MBTL1
SCHEMBL3950019 0.72
SCHEMBL771963 0.71
SCHEMBL965286 0.71 KMT2A (0.82) KMT2AHTTNPC1RAB9AL3MBTL1
SCHEMBL361276 0.71 PKM (0.33) KMT2ASMN1; SMN2MAPTL3MBTL1ALDH1A1
SCHEMBL2645548 0.70 ATM (0.32) KMT2ASMN1; SMN2RAB9AL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070167507-A1 4-Carbox pyrazole derivatives useful as anti-viral agents GLAXO GROUP LIMITED (GB) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167507-A1 4-Carbox pyrazole derivatives useful as anti-viral agents HAVCR2, RPL35, ZC3HAV1L KMT2A 4445/4885HTT 2662/4885SMN1; SMN2 3430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.